A carregar...
032. Moxifloxacin pharmacokinetics in patients with lung infection from non-tuberculous mycobacteria
BACKGROUND: Lung infection from non-tuberculous mycobacteria (NTM), represent a significant clinical problem due to its increased incidence and difficult management. Moxifloxacin (MXF) can play an important role in the treatment of these infections, especially when microbial resistance is an issue....
Na minha lista:
| Publicado no: | J Thorac Dis |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4332104/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.AB032 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|